RYET Launches Co-Funded AI Script and Film Production Program on YeeZo
Key Highlights
- ➤RMB 2 million first-phase budget funds AI script and film production program
- ➤RYET targets approximately 400 scripts and 30 AI films over 12 months
- ➤Jiangxi Ruanyun and co-investor split cumulative operating profits 60% and 40%
- ➤Program films receive RMB 1.2 million production allocation
- ➤Formind Global plans international distribution through video platforms and licensees
Expert Statements
Maggie Fu, Chief Executive Officer of Ruanyun Edai Technology Inc.
“YeeZo was built to turn AI tools into disciplined production: stories, roles, review, rights and delivery. This program applies that approach where it counts, in scripts and films that have to find buyers and audiences. A partner putting capital alongside ours, with no guaranteed return, gives the program a clear commercial test from the start.”
KUALA LUMPUR, Malaysia, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Ruanyun Edai Technology Inc. (NASDAQ: RYET) (“RYET” or the “Company”) announced that its consolidated variable interest entity, Jiangxi Ruanyun Technology Co., Ltd. (“Jiangxi Ruanyun”), has entered into a cooperation agreement to develop, produce and commercially release AI-assisted scripts and AI films using the Company’s YeeZo platform. Jiangxi Ruanyun and its co-investor have each committed RMB 1 million, for a total first-phase budget of RMB 2 million. Neither party receives a guaranteed return or priority repayment of its capital; both are paid only from the program’s profits.
The program combines specialized large language models with human writers and editors. Over an initial 12-month plan, RYET intends to develop approximately 400 new and adapted film and television scripts, from topic selection through writing and review, for sale and licensing. It also intends to acquire and adapt screenplays for approximately 30 AI films to be produced with AI tools and released through YouTube and other platforms. Specific titles will be chosen during the program on the basis of market research, production testing and commercial value.
Get started
Create a free account to read the full story.